Form 8-K - Current report:
SEC Accession No. 0001564590-22-014159
Filing Date
2022-04-12
Accepted
2022-04-12 06:02:31
Documents
59
Period of Report
2022-04-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agle-8k_20220412.htm   iXBRL 8-K 67316
2 EX-99.1 agle-ex991_6.htm EX-99.1 76944
3 EX-99.2 agle-ex992_7.htm EX-99.2 17891
4 EX-99.3 agle-ex993_8.htm EX-99.3 48347
5 GRAPHIC slide-mhur2ds1lpj.jpg GRAPHIC 171392
6 GRAPHIC slide-41qlvanwus2.jpg GRAPHIC 219360
7 GRAPHIC slide-rfwjnatq40j.jpg GRAPHIC 222647
8 GRAPHIC slide-3ce13z11ilk.jpg GRAPHIC 211766
9 GRAPHIC slide-1g0o2okc0g1.jpg GRAPHIC 216666
10 GRAPHIC grsi3kbisube000001.jpg GRAPHIC 12575
11 GRAPHIC slide-flsg2ghzqnt.jpg GRAPHIC 210485
12 GRAPHIC slide-byvwfna0uiu.jpg GRAPHIC 211307
13 GRAPHIC slide-uekqq2224x0.jpg GRAPHIC 138489
14 GRAPHIC slide-smlplffhayx.jpg GRAPHIC 144896
15 GRAPHIC slide-spjjdcewwiy.jpg GRAPHIC 256982
16 GRAPHIC slide-221os20lwxz.jpg GRAPHIC 145620
17 GRAPHIC slide-g3qodho2ayo.jpg GRAPHIC 250003
18 GRAPHIC slide-cuoch1m1n2b.jpg GRAPHIC 117247
19 GRAPHIC grqiq4wy0zhn000001.jpg GRAPHIC 12575
20 GRAPHIC slide-ivhlu2y03ux.jpg GRAPHIC 177729
21 GRAPHIC slide-vsd4pfbkshq.jpg GRAPHIC 250727
22 GRAPHIC slide-5mcjcesm0eo.jpg GRAPHIC 230881
23 GRAPHIC slide-ziseug10t0c.jpg GRAPHIC 154602
24 GRAPHIC slide-dqef2ja2nqe.jpg GRAPHIC 159534
25 GRAPHIC slide-rxmkswmlonf.jpg GRAPHIC 141029
26 GRAPHIC slide-suank32h45z.jpg GRAPHIC 190663
27 GRAPHIC slide-lbskv4o13ea.jpg GRAPHIC 62590
28 GRAPHIC slide-l4zkivsdque.jpg GRAPHIC 394474
29 GRAPHIC slide-nr4imdaxrdg.jpg GRAPHIC 169960
30 GRAPHIC slide-g1ca1j232rp.jpg GRAPHIC 173915
31 GRAPHIC slide-ghsziqd4lic.jpg GRAPHIC 246372
32 GRAPHIC slide-xgyiy1fktsp.jpg GRAPHIC 80754
33 GRAPHIC slide-re1rsdcezsy.jpg GRAPHIC 267100
34 GRAPHIC slide-chw12db2r55.jpg GRAPHIC 191422
35 GRAPHIC slide-wtjg2bcnwmr.jpg GRAPHIC 167146
36 GRAPHIC slide-vth4z12kbih.jpg GRAPHIC 200956
37 GRAPHIC slide-uyfqodedivc.jpg GRAPHIC 210437
38 GRAPHIC slide-mplhf1x2otk.jpg GRAPHIC 223400
39 GRAPHIC slide-pntpcztge1v.jpg GRAPHIC 76263
40 GRAPHIC slide-uxdflcy4ska.jpg GRAPHIC 190430
41 GRAPHIC slide-3lk5ngumvck.jpg GRAPHIC 131793
42 GRAPHIC slide-5nkhdwex1vk.jpg GRAPHIC 161096
43 GRAPHIC slide-uqyy5p3wer2.jpg GRAPHIC 171023
44 GRAPHIC slide-3u5rhihnwpj.jpg GRAPHIC 209364
45 GRAPHIC slide-1a1zzyon5b1.jpg GRAPHIC 239241
46 GRAPHIC slide-ltrdvvltwum.jpg GRAPHIC 195657
47 GRAPHIC slide-jv5tukqyltm.jpg GRAPHIC 156571
48 GRAPHIC slide-szupw2vf5uc.jpg GRAPHIC 214239
  Complete submission text file 0001564590-22-014159.txt   11377368

Data Files

Seq Description Document Type Size
49 XBRL TAXONOMY EXTENSION SCHEMA agle-20220412.xsd EX-101.SCH 5681
50 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20220412_lab.xml EX-101.LAB 19426
51 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20220412_pre.xml EX-101.PRE 11577
53 EXTRACTED XBRL INSTANCE DOCUMENT agle-8k_20220412_htm.xml XML 3558
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 22821028
SIC: 2834 Pharmaceutical Preparations